| Michael I Maggio, MD | |
|
24 Six Pine Ranch Rd, Batesville, IN 47006-1399 | |
| (812) 933-5110 | |
| (812) 933-3794 |
| Full Name | Michael I Maggio |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 42 Years |
| Location | 24 Six Pine Ranch Rd, Batesville, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841275682 | NPI | - | NPPES |
| 100325300A | Medicaid | IN | |
| 0597528 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 01041890A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Suburban Home Health Llc | Noblesville, IN | Home health agency |
| Margaret Mary Community Hospital Inc | Batesville, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Margaret Mary Community Hospital Inc | 5193714335 | 70 |
News Archive
A research team from The University of Texas at Arlington is working with the Army Research Laboratory to develop nanophotonic devices that could have applications in thermal imaging and resonant filtering.
A health law program that directs $5 billion for coverage of otherwise uninsurable people through state-run high-risk insurance pools has attracted only 8,011 people according to health department enrollment figures, The New York Times reports. That's a paucity compared to the hundreds of thousands of people government actuaries predicted would flock to the program causing it to run out of money too early.
Working with animals, a team of scientists reports it has delivered stem cells to the brain with unprecedented precision by threading a catheter through an artery and infusing the cells under real-time MRI guidance.
According to new research presented today at Digestive Disease Week, drinking caffeinated beverages may benefit some people who are at high-risk for liver disease. Conversely, a study by researchers from India found that soda drinkers, who represent a huge percentage of the American population, may actually have an increased risk of developing esophageal cancer.
New positive Phase II results from an interim analysis of the randomised Phase I/II study involving the company's investigational haematology/oncology compound volasertib in newly diagnosed patients with acute myeloid leukemia (AML) considered ineligible for intensive remission induction therapy were presented at the 54th American Society of Hematology (ASH) annual meeting in Atlanta, USA.
› Verified 4 days ago
| Entity Name | Margaret Mary Community Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558368449 PECOS PAC ID: 5193714335 Enrollment ID: O20040511001443 |
News Archive
A research team from The University of Texas at Arlington is working with the Army Research Laboratory to develop nanophotonic devices that could have applications in thermal imaging and resonant filtering.
A health law program that directs $5 billion for coverage of otherwise uninsurable people through state-run high-risk insurance pools has attracted only 8,011 people according to health department enrollment figures, The New York Times reports. That's a paucity compared to the hundreds of thousands of people government actuaries predicted would flock to the program causing it to run out of money too early.
Working with animals, a team of scientists reports it has delivered stem cells to the brain with unprecedented precision by threading a catheter through an artery and infusing the cells under real-time MRI guidance.
According to new research presented today at Digestive Disease Week, drinking caffeinated beverages may benefit some people who are at high-risk for liver disease. Conversely, a study by researchers from India found that soda drinkers, who represent a huge percentage of the American population, may actually have an increased risk of developing esophageal cancer.
New positive Phase II results from an interim analysis of the randomised Phase I/II study involving the company's investigational haematology/oncology compound volasertib in newly diagnosed patients with acute myeloid leukemia (AML) considered ineligible for intensive remission induction therapy were presented at the 54th American Society of Hematology (ASH) annual meeting in Atlanta, USA.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael I Maggio, MD Po Box 236, Batesville, IN 47006-0236 Ph: (812) 933-5441 | Michael I Maggio, MD 24 Six Pine Ranch Rd, Batesville, IN 47006-1399 Ph: (812) 933-5110 |
News Archive
A research team from The University of Texas at Arlington is working with the Army Research Laboratory to develop nanophotonic devices that could have applications in thermal imaging and resonant filtering.
A health law program that directs $5 billion for coverage of otherwise uninsurable people through state-run high-risk insurance pools has attracted only 8,011 people according to health department enrollment figures, The New York Times reports. That's a paucity compared to the hundreds of thousands of people government actuaries predicted would flock to the program causing it to run out of money too early.
Working with animals, a team of scientists reports it has delivered stem cells to the brain with unprecedented precision by threading a catheter through an artery and infusing the cells under real-time MRI guidance.
According to new research presented today at Digestive Disease Week, drinking caffeinated beverages may benefit some people who are at high-risk for liver disease. Conversely, a study by researchers from India found that soda drinkers, who represent a huge percentage of the American population, may actually have an increased risk of developing esophageal cancer.
New positive Phase II results from an interim analysis of the randomised Phase I/II study involving the company's investigational haematology/oncology compound volasertib in newly diagnosed patients with acute myeloid leukemia (AML) considered ineligible for intensive remission induction therapy were presented at the 54th American Society of Hematology (ASH) annual meeting in Atlanta, USA.
› Verified 4 days ago
Paul D Jarvis, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 24 Six Pine Ranch Rd, Batesville, IN 47006 Phone: 812-933-5110 |